Compare VRTX to:
After Hours: 0.00 N/A (N/A) 7:00pm ET
| Last Trade: | 39.38 |
|---|---|
| Trade Time: | Nov 25 |
| Change: | 0.00 (0.00%) |
| Prev Close: | 39.38 |
| Open: | N/A |
| Bid: | 36.50 x 100 |
| Ask: | N/A |
| 1y Target Est: | 42.75 |
| Day's Range: | N/A - N/A |
|---|---|
| 52wk Range: | 20.94 - 41.75 |
| Volume: | 0 |
| Avg Vol (3m): | 2,155,670 |
| Market Cap: | 7.14B |
| P/E (ttm): | N/A |
| EPS (ttm): | -3.82 |
| Div & Yield: | N/A (N/A) |
| Tue, Nov 24 | The Technical Indicator: U.S. markets hesitate at the 2009 peakat MarketWatch |
| Mon, Nov 23 | Become a Recessionista? Not in This Stock MarketTradingMarkets.com |
| Sat, Nov 21 | [$$] The Hunt for Tech Stocks, Broadly Definedat Barrons.com |
| Fri, Nov 20 | Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor ConferencesBusiness Wire |
| Tue, Nov 17 | UPDATE - InterMune to modify hep C study to drop one dosageat Reuters |
| Tue, Nov 17 | InterMune shares fall on change in hepatitis studyAP |
| Tue, Nov 17 | Isis Cholesterol Drug Effective, but Safety a Worry: BioBuzzat TheStreet.com |
| Tue, Nov 17 | Tech stocks off the beaten pathat Fortune |
| Tue, Nov 17 | InterMune Hep C Drug Hit With Liver Tox Worry: BioBuzzat TheStreet.com |
| Tue, Nov 17 | Vertex Pharm downgraded by MerrimanBriefing.com |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.